<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01963988</url>
  </required_header>
  <id_info>
    <org_study_id>2013-05-127</org_study_id>
    <secondary_id>ksleedr</secondary_id>
    <nct_id>NCT01963988</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients</brief_title>
  <official_title>Pilot Study for Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the EAU (European Association of Urology) guidelines, the ulcer type bladder pain syndrome
      (BPS) should be treated with transurethral resection (TUR) or coagulation (TUC) of ulcer.

      But, Up to date, there was no study to compare the therapeutic efficacy of TUR with TUC in
      ulcer type BPS patients.

      We assume TUR have a more therapeutic effect than TUC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence-free survival between TUC and TUR</measure>
    <time_frame>Until 12 months after the last subject be enrolled</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of voiding dairy parameters(mean number of micturition,Urgency etc) after each treatment</measure>
    <time_frame>1,3,6,9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF)</measure>
    <time_frame>1,3,6,9 and 12months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Global Response Assessment(GRA) score</measure>
    <time_frame>1,3,6,9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of EQ-5D (EuroQOL five dimensions) Health Questionnaire score</measure>
    <time_frame>1,3,6,9 and 12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Patient Global Assessment(PGA)</measure>
    <time_frame>12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Brief Pain Inventory-short form(BPI-sf) score</measure>
    <time_frame>9 and 12months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">126</enrollment>
  <condition>Bladder Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>Transurethral Coagulation (TUC)</arm_group_label>
    <description>This cohort patients will be managed with Transurethral Coagulation (TUC) of IC ulcer lesion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transurethral Resection(TUR)</arm_group_label>
    <description>This cohort patients will be managed with transurethral resection(TUR) of IC ulcer lesion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transurethral Coagulation (TUC)</intervention_name>
    <arm_group_label>Transurethral Coagulation (TUC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transurethral Resection(TUR)</intervention_name>
    <arm_group_label>Transurethral Resection(TUR)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be enrolled diagnosed with bladder pain syndrome by ESSIC proposal.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female aged 18 yrs or greater

          2. Patients diagnosed with BPS(Bladder Pain Syndrome)

          3. Symptom persisted more than 6 months

          4. Pain VAS â‰¥4

          5. O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) scores 12 or greater with pain
             and nocturia domain scores &gt; 2.

          6. Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF) &gt;13

          7. No history of cystoscopy within 2yrs.

        Exclusion Criteria:

          1. History of augmentation cystoplasty or previous transurethral coagulation/resection
             due to BPS

          2. Child-bearing potential, pregnant or nursing women.

          3. Mean voided volume lesser than 40ml or over than 400ml.

          4. Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.

          5. Urinary tract infection during run-in periods.

          6. Genitourinary tuberculosis or bladder,urethral and prostate cancer

          7. Recurrent urinary tract infection

          8. History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal
             delivery or Cesarean section,prostate operation or treatment etc within 6months.

          9. Neurologic disease history of cerebral infarction,multiple sclerosis or parkinsonism
             etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2013</study_first_submitted>
  <study_first_submitted_qc>October 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2013</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>KYU-SUNG LEE</investigator_full_name>
    <investigator_title>professor,MD,PhD</investigator_title>
  </responsible_party>
  <keyword>Bladder Pain Syndrome</keyword>
  <keyword>Transurethral Resection of Ulcer</keyword>
  <keyword>Transurethral Coagulation of Ulcer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
    <mesh_term>Cystitis, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

